Private Equity 3 Hours

Last updated: May 22, 2026, 8:30 AM ET

Tech IPO Pipeline

A smart‑ring specialist has filed for a New York debut, setting the stage for a potential valuation near $1.5bn as it seeks to raise capital for global expansion. The filing follows a trend of wearable‑tech IPOs that aim to capture a share of the $120bn market projected for 2026. Investors will watch the company’s earnings trajectory closely, given the sector’s recent volatility. Oura files IPO

European Vitamin Consolidation

Belgian family office Damier and UK‑based Avista are buying Sanotact, a Dutch vitamins producer, for an undisclosed sum that analysts estimate could reach €120mn. The deal aims to combine Sanotact’s niche formulations with Avista’s distribution network, positioning the combined entity to capitalize on rising demand for functional foods in Europe. The transaction underscores a broader trend of consolidation in the health‑supplement sector. Avista and Damier acquire Sanotact

Pain Management Focus

Charterhouse Capital, Iron Path and Revelar Capital are targeting five pain‑management platforms, signalling a shift toward specialty healthcare within private equity. The firms plan to fund add‑on acquisitions and digital integration to boost margins, following a wave of successful exits in the sector. The strategy reflects investor confidence that chronic pain solutions will drive long‑term revenue growth amid an aging population. PE targets pain management

Scale‑Up Fund Expansion

The €5bn Scaleup Europe Fund has outlined a portfolio of over 100 high‑growth companies it could back, spanning fintech, biotech and climate tech. The fund aims to deploy capital in stages, prioritising firms with proven revenue models and clear paths to profitability. This move signals renewed appetite for European scale‑ups after a period of cautious investment. Scaleup Europe Fund list